Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?

Published on 8 Jun 2024 on Zacks · via Yahoo Finance

Kodiak Sciences (KOD) is evaluating its lead candidate, tarcocimab, in a late-stage study for...

Read the rest of the article

Start tracking your investments with Statfolio

Over the last 7 days, the UK market has dropped by 1.0%, but it has risen by 6.9% over the past y...

Simply Wall St. · via Yahoo Finance 15 Nov 2024

Kodiak Sciences (KOD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism abo...

Zacks · via Yahoo Finance 21 Jul 2024

Kodiak Sciences (KOD) is evaluating its lead candidate, tarcocimab, in a late-stage study for...

Zacks · via Yahoo Finance 8 Jun 2024

Kodiak Sciences Inc. KOD reported first-quarter 2024 loss per share of 82 cents, narrower than th...

Zacks via Yahoo Finance 17 May 2024

With the business potentially at an important milestone, we thought we'd take a closer look at Ko...

Simply Wall St. via Yahoo Finance 1 May 2024

Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript March 28, 2024 Kodiak Sciences...

Insider Monkey via Yahoo Finance 1 Apr 2024

Kodiak Sciences Inc. KOD incurred a loss per share of $1.13 in the fourth quarter of 2023, wider ...

Zacks via Yahoo Finance 1 Apr 2024

Last week, two of the three widely followed indexes closed in the green, while one remained close...

Zacks via Yahoo Finance 1 Apr 2024

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. ...

Benzinga 28 Mar 2024

Shares of Kodiak Sciences Inc. KOD fell sharply during Thursday’s session after the company rep...

Benzinga 28 Mar 2024